In 2023, India’s import of pharmaceutical products stood at $2.40 billion. Forecasted data indicates a steady increase in imports over the next five years, starting with $2.4635 billion in 2024 and reaching $2.7329 billion by 2028. Year-on-year growth rates demonstrate a consistent upward trend, with imports increasing by 2.81% in 2025, 2.68% in 2026, 2.56% in 2027, and 2.45% in 2028. The compound annual growth rate (CAGR) over this period is approximately 2.63%.

Future trends to watch include:

Growing demand for advanced medical treatments and therapies.
Government policies and regulations affecting pharmaceutical imports and pricing.
Potential impacts of global supply chain disruptions on import volumes.